magnetic stimulation of skeletal and respitatory muscle for COVID-19
- Conditions
- COVID-19magnetic stimulation therapy
- Registration Number
- JPRN-jRCTs032210201
- Lead Sponsor
- Sakai Tomoko
- Brief Summary
The study will be terminated without being initiated due to difficulties in obtaining cases.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 0
Part 1:
1) Healthy persons who do not have cardiopulmonary diseases
2) Men or women more than 19years old at informed consent
3) Persons from whom informed consent were obtained with sufficient understanding and by their free will after detailed explanation on participating this study
Part 2:
1) Patients with severe COVID-19 in ICU of Tokyo Medical and Dental University
2) men or women who are more than 19 years at informed consent
3) Patients from whose proxies informed consent were obtained with sufficient understanding and by their free will after detailed explanation on participating this study ( from patients if possible)
1) pace-maker user
2) The patient who is judged to be inappropriate as a study subject by a study responsibility doctor and a study allotment doctor (the following study responsibility doctors)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Part I: Healthy persons<br>(Outcomes assessment)<br>The changes of the following outcomes between before with 1, 2 and 3weeks after stimulation <br>1. The muscle thickness and the muscle mass area at the center of bilateral quadriceps by ultrasonography<br>2. The thickness of diaphragm by ultrasonography<br>3. The circumference of the thighs at 5, 10, 15, 20 cm beyond the upper edge of the patella <br>Part 2: Patients with severe COVID-19 <br>(Outcomes assessment)<br>The changes of the following outcomes between before with every week to the end of sedation and the start of active movements <br>1. The muscle thickness and the muscle mass area at the center of bilateral quadriceps by ultrasonography<br>2. The thickness of diaphragm by ultrasonography<br>3. The circumference of the thighs at 5, 10, 15, 20 cm beyond the upper edge of the patella
- Secondary Outcome Measures
Name Time Method